WEE1 and ovarian cancer: To further validate the potential of Wee1 inhibition as a chemopreventive therapy, a panel of premalignant cell cultures was treated with Adavosertib, together with a panel of HNSCC and two ovarian tumor cell lines as reference, since ovarian cancer is known to be vulnerable to Wee1 inhibition in clinical studies20,22.